Alzheimer's drug trial results boost Biogen Idec market cap by $40bn

US drugmaker's market cap has risen fivefold over last five years.



via IBTimes.co.uk : Articles by Jerin Mathew http://ift.tt/1ATLdqA March 21, 2015 at 11:11AM http://ift.tt/eA8V8J